Dexfosfoserine
As of the edition of 20 October 2026, Dexfosfoserine is a small molecule: marketed, first approved in 1988 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1988
- Kind
- Small molecule
- Brand name
- Vitasprint B12
- First approved
- 27 July 1988 (CH)
- Approvals on record
- 2 in 1 region
- Holder of the most recent approval
- IBSA Institut Biochimique; 2 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| IBSA Institut Biochimique | Applicant | 1997 to now |